YARROW BIOSCIENCE, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
YARROW BIOSCIENCE, INC. (YARW) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 4.00% for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2018-03-28
- YARROW BIOSCIENCE, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2017 was 4.00%, a 100.00% increase from fiscal 2016.
- YARROW BIOSCIENCE, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2016 was 2.00%, a 100.00% increase from fiscal 2015.
- YARROW BIOSCIENCE, INC. effective income tax rate reconciliation, tax credit, percent for fiscal 2015 was 1.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2017-12-31 | 4.00% 10-K · filed 2018-03-28 |
| 2016-12-31 | 2.00% 10-K · filed 2018-03-28 |
| 2015-12-31 | 1.00% 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |